Last reviewed · How we verify
NCT05493696
Antigravity Treadmill Training on Gait Characteristics and Balance
NA trial testing Antigravity treadmill in Burns in 55 participants. Completed in 28 July 2022.
15 July 2022
Quick facts
| Lead sponsor | Umm Al-Qura University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 55 |
| Start date | 15 June 2022 |
| Primary completion | 15 July 2022 |
| Estimated completion | 28 July 2022 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Antigravity treadmill
- Traditional physical therapy program
Conditions studied
- Burns — all drugs for Burns →
Sponsor
Umm Al-Qura University
Who can join
Adults 18 to 35, any sex, with Burns. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Severe burn injuries are associated with hypermetabolic responses and increased catabolism. These generalized changes lead to a vast loss of muscle mass and cause reduced muscle strength and endurance, limited walking ability, and reduced functional mobility Recently, the antigravity treadmill or lower body positive pressure (LBPP) technology has been developed as a unique system of maintaining a participant's body weight all through treadmill training and developing low-load treadmill walking using a unique treadmill system that allows gaining the benefits of low-load treadmill walking without interrupting with locomotion dynamics
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05493696
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burns
Currently open trials in the same condition.
- NCT07259668 — Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns · recruiting
- NCT07248930 — Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns · recruiting
- NCT07313735 — The Effect of Cartoon Character-Printed Band Use During Burn Dressing on Fear, Stress, Pain, and Physiological Parameter · NA · recruiting
- NCT07142824 — Comparison Between Burn Dressing Using Tilapia-Fish Skin Versus Regular Dressing · NA · recruiting
- NCT07277166 — The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function Af · NA · recruiting
Other Umm Al-Qura University trials
Trials by the same sponsor.
- NCT07322861 — Virtual Reality-Based vs Traditional Physiotherapy for Balance, Frailty, and Fall Prevention in Adults Aged 45 Years and · NA · not yet recruiting
- NCT06735963 — Evaluating the Impact of a Meta Quest 3 Gamified VR Rehabilitation Program in Knee Osteoarthritis · NA · not yet recruiting
- NCT07515417 — Effect of Magnesium Supplementation on Sleep Quality and Cognitive Function in Saudi Adults · NA · active not recruiting
- NCT06974435 — Interval Training and Electromagnetic Therapy on Cardiovascular Disease Risk in Diabetic Elderly · NA · completed
- NCT06974422 — Weight Off-loading Training, Cardiovascular Indices, Diabetes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05493696 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Umm Al-Qura University
- Last refreshed: 9 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493696.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing